Breaking News
-
Kintor Pharma completes first batch patient dosing in phase I/II clinical trial of Pyrilutamide to treat acne vulgaris
168 0Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, announced the clinical…
Read more -
Drug exports go up 18.7% to US$ 24.44 bn in FY 21
52 0India’s pharmaceutical exports has increased 18.7 per cent to US$…
Read more -
Prime Minister Narendra Modi interacts with medical experts & Pharma Leaders
22 0Prime Minister Narendra Modi interacted with leaders of pharmaceutical industry…
Read more -
Angle launches clinical labs to provide circulating tumour cell analysis services
60 1Angle plc, a world-leading liquid biopsy company, announced that it…
Read more -
Pharma Stocks under pressure. Why does the Pharma sector continue to be an attraction?
39 0The BSE Healthcare (HC) index of 70 pharmaceutical and healthcare…
Read more -
“My motto has always been, to provide ‘Health to those without Wealth” – Dr. Harsh Vardhan
86 0Dr Harsh Vardhan, Union Minister for Health and Family Welfare…
Read more -
Takeda secures global rights from Ovid Therapeutics to develop & commercialize soticlestat to treat Dravet syndrome and Lennox-Gastaut syndrome
69 0Takeda Pharmaceutical Company Limited and Ovid Therapeutics, a biopharmaceutical company,…
Read more -
Boston to acquire global surgical business of Lumenis LTD from Baring Private Equity Asia
69 0Boston Scientific Corporation announced that it has entered into a…
Read more -
Bio-Techne to acquire Austin, Texas-based biotechnology company, Asuragen for US$ 215 million
117 0Bio-Techne Corporation, a global life sciences company, announced it has…
Read more -
Bio-Techne Corporation, a global life sciences company, announced it has reached an agreement to acquire Asuragen Inc, a biotechnology company for initial consideration of US$ 215 million in cash plus contingent
57 0BioIVT, a leading provider of research models and services for…
Read more